-
Pirkmajer, Sergej; Garcia-Roves, Pablo M.; Rustan, Arild Christian & Chibalin, Alexander V.
(2022).
Editorial: Untangling energy metabolism in skeletal muscle: From physiology to pharmacology.
Frontiers in Physiology.
ISSN 1664-042X.
13.
doi:
10.3389/fphys.2022.1113860.
-
Viktorsson, Elvar Örn; Åstrand, Ove Alexander Høgmoen; Rustan, Arild; Thoresen, G. Hege; Kase, Eili Tranheim & Rongved, Pål
(2015).
Analogs of 22-S-hydroxycholesterol as potential Liver X Receptor-modulators: Synthesis and biological evaluation.
-
Feng, Yuan Zeng; knabenes, Irlin Knivsland; Bakke, Siril S.; Lund, Jenny; Lee, Y.K. & kimmel, Alan
[Vis alle 9 forfattere av denne artikkelen]
(2015).
Increased lipid oxidation and decreased lipid storage in myotubes lacking the lipid droplet binding protein perilipin2.
-
Kong, Xiang Yi; Nesset, Cecilie Kåsi; Schjalm, Camilla; Løberg, Else Marit; Rustan, Arild & Thoresen, G. Hege
[Vis alle 8 forfattere av denne artikkelen]
(2014).
NCU-G1GT/GT MICE: A LONG-LIVED MODEL FOR LIVER FIBROSIS.
-
Feng, Yuan Zeng; knabenes, Irlin Knivsland; Lund, Jenny; Lee, Y.K.; kimmel, Alan & Thoresen, G. Hege
[Vis alle 8 forfattere av denne artikkelen]
(2014).
Increased lipid oxidation and decreased lipid storage in myotubes lacking perilipin2.
-
Kase, Eili Tranheim; Lund, Jenny; Feng, Yuan Zeng; Langleite, Torgrim Mikal; Aas, Vigdis & Jensen, Jan S.
[Vis alle 11 forfattere av denne artikkelen]
(2013).
Effect of exercise on fatty acid and glucose metabolism in cultured human myotubes.
Diabetologia.
ISSN 0012-186X.
56,
s. S250–S250.
-
Smith, Robert; Johansen, Harald Thidemann; Jacobsen, Linn Løkken; Voreland, Anette Larsen; Rustan, Arild & Thoresen, G. Hege
[Vis alle 7 forfattere av denne artikkelen]
(2013).
Simvastatin inhibits legumain activity and processing in human myotubes.
-
Covington, Jeffrey D.; Galgani, Jose E.; Rustan, Arild; Zhang, Zhengyu; Moro, Cedric & Smith, Steven R.
[Vis alle 8 forfattere av denne artikkelen]
(2013).
Muscle perilipin 3 is reduced using in vitro and in vivo exercise models and negatively associated with exercise lipid oxidation.
The FASEB Journal.
ISSN 0892-6638.
27.
-
Bakke, Siril Skaret; Feng, Yuan Zeng; Rustan, Arild; Hjelmesæth, Jøran; Thoresen, G. Hege & Aas, Vigdis
(2012).
Lower lipolysis to counteract the development of type 2 diabetes mellitus - evidence from myotubes established from extremely obese subjects.
-
Aas, Vigdis; Bakke, Siril Skaret; Nikolic, Natasa; Hjelmesæth, Jøran; Thoresen, G. Hege & Rustan, Arild
(2012).
Altered energy metabolism in skeletal muscle cells derived from morbidly obese subjects.
-
Bakke, Siril Skaret; Nikolic, Natasa; Rustan, Arild; Hjelmesæth, Jøran; Thoresen, G. Hege & Aas, Vigdis
(2012).
ALTERED ENERGY METABOLISM IN SKELETAL MUSCLE CELLS DERIVED FROM MORBIDLY OBESE INDIVIDUALS.
Vis sammendrag
Introduction: Obesity is strongly associated with insulin resistance and type 2 diabetes (T2D). It has been revealed that less than 1 out of 3 morbidly obese subjects have T2D (Obes Surg 2010; 20:302-7), indicating that many morbidly obese subjects possess certain characteristics that
protect them against developing T2D.
Skeletal muscle is an important organ involved in fatty acid and glucose
metabolism and therefore one of the organs where insulin resistance is most prominent. Metabolic flexibility is defined as the muscle’s ability to change energy metabolism between fed and fasted conditions, and this
ability is reduced in insulin resistance and T2D.
Methods: We examined fatty acid and glucose metabolism as well as
metabolic flexibility in human skeletal muscle cells using radiolabeled precursors. The cells were derived from lean healthy subjects (BMI 23±0.9 kg/m2), morbidly obese with normal glucose tolerance (BMI 44±2.0 kg/m2) and morbidly obese subjects with T2D (BMI 43±1.5 kg/m2).
Results: A 2-fold increase in fatty acid metabolism was observed in
cells established from morbidly obese subjects (measured as accumulation and oxidation of oleic acid) and a approximately 40% lower metabolic flexibility (measured as the ability to switch from fatty acid to glucose oxidation) compared to cells from lean subjects. Triacylglycerol
lipolysis was 30% higher for obese T2D subjects compared to the other
groups.
Conclusion: Muscle cells derived from morbidly obese showed increased lipid metabolism, but had a lower metabolic flexibility than cells from lean. Obese subjects with T2D had increased lipolysis, which may be important for development of T2D.
Conflict of Interest
None disclosed
Funding
Norwegian Research Council, Norwegian Diabetes Foundation, Freia Chocolade Fabriks Medical Foundation and Anders Jahre’s Foundation.
-
Bakke, Siril Skaret; Nikolic, Natasa; Rustan, Arild; Hjelmesæth, Jøran; Thoresen, G. Hege & Aas, Vigdis
(2012).
Altered energy metabolism in skeletal muscle cells derived from morbidly obese donors.
-
Bakke, Siril Skaret; Nikolic, Natasa; Moro, Cedric; Lauvhaug, Line; Hessvik, Nina Pettersen & Thoresen, G. Hege
[Vis alle 7 forfattere av denne artikkelen]
(2011).
DIFFERENT HANDLING OF PALMITIC ACID AND OLEIC ACID IN HUMAN SKELETAL MUSCLE CELLS.
-
Bakke, Siril Skaret; Nikolic, Natasa; Moro, Cedric; Lauvhaug, Line; Hessvik, Nina Pettersen & Thoresen, G. Hege
[Vis alle 7 forfattere av denne artikkelen]
(2011).
Different handling of palmitic acid and oleic acid in human skeletal muscle cells.
-
Lauvhaug, Line; Bakke, Siril Skaret; Thoresen, G. Hege & Rustan, Arild
(2011).
Different handling of oleic, palmitic, linoleic and eicosapentaenoic acids in cultured human skeletal muscle cells.
-
Halle, Ingeborg F.; Nikolic, Natasa; Bakke, Siril Skaret; Thoresen, G. Hege; Rustan, Arild & Aas, Vigdis
(2011).
Electrical pulse stimulation of cultured human skeletal muscle cells as a model of exercise in vitro.
-
Dembinska-Kiec, A.; Knapp, A.; Kiec-Wilk, B.; Sliwa, A.; Czech, U. & Korczynska, M.
[Vis alle 7 forfattere av denne artikkelen]
(2010).
Metabolism of endothelial and adipose stromal vascular (SVF) fraction in the presence of fatty acids.
European Journal of Clinical Investigation.
ISSN 0014-2972.
40,
s. 78–79.
-
Nikolic, Natasa; Bakke, Siril Skaret; Thoresen, G. Hege; Rustan, Arild & Aas, Vigdis
(2010).
Chronic electrical pulse stimulation of cultured human skeletal muscle cells as an in vitro model of exercise.
-
Nikolic, Natasa; Bakke, Siril Skaret; Thoresen, G. Hege; Rustan, Arild & Aas, Vigdis
(2010).
Energimetabolismen i humane skjelettmuskelceller - Utvikling av in vitro treningsmodell.
-
Nikolic, Natasa; Bakke, Siril Skaret; Thoresen, G. Hege; Rustan, Arild & Aas, Vigdis
(2010).
Chronic electrical pulse stimulation of cultured human skeletal muscle cells as an in vitro model of exercise.
-
Hessvik, Nina Pettersen; Bakke, Siril Skaret; Thoresen, G. Hege; Rustan, Arild & Kase, Eili Tranheim
(2010).
Effects of 22-S-hydroxycholesterol (a liver X receptor modulator) on Lipid Metabolism.
Vis sammendrag
Liver X receptors (LXRs) play a crucial role in regulation of cholesterol, lipid and carbohydrate metabolism. 22-S-hydroxycholesterol (22-S-HC) has been shown to act as an LXR antagonist and to reduce de novo lipogenesis and lipid accumulation, as well as to increase glucose uptake in human skeletal muscle cells (myotubes). The aim of the present study was to further investigate the effects of 22-S-HC on lipid and glucose metabolism in human-derived cell lines from metabolic active tissues important for development of obesity and type 2 diabetes. We also wanted to explore the effects of 22-S-HC on plasma lipids in vivo in rats. The results show that de novo lipogenesis from [14C]acetate was decreased by 22-S-HC in myotubes and HepG2 (liver) cells, whereas increased in SGBS cells (adipocytes) and unaffected in CaCo-2 cells (intestinal cells). This was partly reflected by regulation of the lipogenic genes, sterol regulatory element binding transcription factor 1 (SREBF1) and fatty acid synthase (FASN), as measured by RT qPCR. Live imaging showed that the number of lipid droplets (LDs) was increased in SGBS cells, decreased in HepG2 cells and unaffected in myotubes by 22-S-HC treatment. Furthermore, exposure to 22-S-HC increased and tended to increase glucose uptake in myotubes and SGBS cells, respectively. However, apoA1-dependent cholesterol efflux was unaffected by 22-S-HC. These observations show that 22-S-HC differently affect distinct LXR-regulated processes, and that 22-S-HC not solely acts as an antagonist to LXR, but also stimulate some LXR-regulated processes. Furthermore, the results suggest that 22-S-HC might reduce ectopic fat accumulation and result in a more favorable lipid distribution. To investigate the effects of 22-S-HC in vivo, high-fat fed Wistar rats were given 30 mg/kg/day of 22-S-HC for 3 weeks. The 22-S-HC treated rats showed significantly reduced body weight gain compared to the control animals and reduced plasma levels of free fatty acids and triacylglycerol. Therefore, compounds with properties similar to 22-S-HC may be of importance in search towards better treatments for obesity and type 2 diabetes.
-
Bakke, Siril Skaret; Hessvik, Nina Pettersen; Thoresen, G. Hege & Rustan, Arild
(2010).
The impact of the n-3 fatty acid eicosapentaenoic acid (EPA) on metabolic switching in human skeletal muscle cells.
Vis sammendrag
Our recent studies with differentiated human skeletal muscle cells (myotubes) suggests a positive role for the n-3 fatty acid eicosapentaenoic acid (EPA) compared to the other monounsaturated and saturated fatty acids (FAs) in improving overall metabolic switching in skeletal muscle in vitro. This might contribute to the beneficial health effects of dietary intake of very long-chain n-3 fatty acids.
In a study using myotubes established from lean healthy donors we showed that incubation of EPA for one day increased suppressibility, the ability of acute glucose to suppress FA oxidation. Substrate-regulated flexibility, the ability to increase FA oxidation when changing from a high glucose, low fatty acid condition (“fed”) to a high fatty acid, low glucose (“fasted”) condition, was also increased by EPA. Adaptability, the capacity to increase FA oxidation with increasing FA availability, was enhanced after pretreatment with several FAs (EPA, linoleic acid (LA) and palmitic acid (PA)). EPA present in the cell after one day was significantly less than the other FAs, probably due to a higher oxidation rate. Yet, EPA, LA and oleic acid (OA) treatment increased the number of lipid droplets (LDs) in myotubes. LD volume and intensity, as well as mitochondrial mass were independent of FA pretreatment. Microarray and PCR analysis showed that EPA regulated more genes than the other FAs, and that specific pathways involved in carbohydrate metabolism were induced only by EPA.
The present study suggests a favorable effect of EPA on skeletal muscle metabolic switching. Additional experiments with ALA (α-linolenic acid) and DHA (docosahexaenoic acid) indicated that the metabolic effects could be due to a general quality of n-3 FAs. Based on findings from this study we also suggest the use of three parameters called suppressibility, adaptability and substrate-regulated flexibility in functional studies of fuel selection and energy metabolism in cell cultures.
References:
Hessvik NP, Bakke SS et al, “Metabolic switching of human myotubes is improved by n-3 fatty acids.”, J Lipid Res. 2010 Aug;51(8):2090-104.
-
Bakke, Siril Skaret; Hessvik, Nina Pettersen; Thoresen, G. Hege & Rustan, Arild
(2010).
HANDLING OF PALMITIC ACID AND OLEIC ACID IN HUMAN SKELETAL MUSCLE CELLS.
Vis sammendrag
Obesity seems to be associated with type of dietary fat, and a positive association with saturated fatty acids (SFA) and a negative association with monounsaturated fatty acids (MUFA) have been found. In human skeletal muscle cells, SFA is reported to preferentially accumulate as diacylglycerol (DAG) and ceramides, while MUFA is reported to preferentially accumulate as triacylglyserol (TAG). In accordance to this, we have previously shown that the number of lipid droplets (LDs) is two-fold higher after pretreatment with oleic acid (OA) than palmitic acid (PA). PA has also been found to be more oxidized than OA. We wanted to study the handling of OA and PA in human myotubes, regarding uptake, oxidation and storage.
Satellite cells were isolated from biopsy samples from M. obliquus internus abdominis and differentiated into multinucleated myotubes. Myotubes were pretreated for 24 h with 100 μM OA/PA, and the metabolism of [14C] OA/PA was studied. For imaging with fluorescence microscope, myotubes were stained with Bodipy and Hoescht, and LDs and nuclei were counted.
Our results show that in human myotubes more OA than PA was stored, while PA was oxidized to a higher degree than OA. OA was stored mostly as TAG, while more PA than OA was stored in phospholipids. When long fatty acyl CoA synthetase was inhibited by Triacsin C, the storage of OA in TAG and DAG was reduced, but storage of PA remained unchanged. More OA than PA was subject to lipolysis; however the lipolysis seemed to parallel the storage in LDs. Thus, lipolysis might not be dependent on saturation of fatty acids stored but on the amount of lipids stored.
In conclusion, our results indicate that PA has a higher turnover and is more available for oxidation than OA. This might be of importance in further studies of the link between intracellular lipids and the development of insulin resistance.
-
Aas, Vigdis; Hessvik, Nina Pettersen; Thoresen, G. Hege & Rustan, Arild
(2010).
Chronic hyperglycemia impairs mitochondrial function in human myotubes.
-
Rustan, Arild
(2010).
The impact of eicosapentaenoic acid (EPA) on regulation of fatty acid metabolism, metabolic flexibility and gene expression in human skeletal muscle cells.
Vis sammendrag
Our recent studies with differentiated human skeletal muscle cells (myotubes) suggests a positive role for eicosapentaenoic acid (EPA) compared to the other fatty acids (FAs) in improving overall energy metabolism and metabolic switching in skeletal muscle, which may contribute to the beneficial effects of dietary intake of very long-chain n-3 fatty acids.
In a study using myotubes established from lean donors we showed that EPA increased suppressibility, the ability of acute glucose to suppress FA oxidation. Substrate-regulated flexibility, the ability to increase FA oxidation when changing from a high glucose, low fatty acid condition (“fed”) to a high fatty acid, low glucose (“fasted”) condition, was increased by EPA. Adaptability, the capacity to increase FA oxidation with increasing FA availability, was enhanced after pretreatment with EPA, linoleic acid (LA) and palmitic acid (PA). EPA per se accumulated less in the cells, however, EPA, LA and oleic acid (OA) treatment increased the number of lipid droplets (LDs) in myotubes. LD volume and intensity, as well as mitochondrial mass were independent of FA pretreatment. Microarray and PCR analysis showed that EPA regulated more genes than the other FAs and specific pathways involved in carbohydrate metabolism were induced only by EPA. The present study suggest a favorable effect of EPA on skeletal muscle metabolic switching and glucose utilization. Additional experiments with ALA and DHA indicated that the metabolic effects could be due to a general quality of n-3 FAs. Based on finding from this study we also suggest the use of three parameters called suppressibility, adaptability and substrate-regulated flexibility in functional studies of fuel selection and energy metabolism in cell cultures.
In another study we wanted to identify the potential effects of EPA and a synthetic fatty acid derivative (TTA) on energy metabolism, insulin resistance and gene expression (PCR). Here we compared the effects of EPA, TTA, and OA in myotubes established from obese individuals with type 2 diabetes and obese healthy control subjects. Our results suggest that 1) mitochondrial dysfunction in diabetic myotubes was caused by disturbances downstream of fatty acid β-oxidation; 2) EPA promoted accumulation of triacylglycerol (TAG), enhanced β-oxidation, and increased glucose oxidation; and 3) TTA improved complete palmitic acid oxidation in diabetic myotubes, opposed increased lipid accumulation, and increased glucose oxidation.
-
Rustan, Arild Chr.; Wettergreen, Marianne; Hessvik, Nina; Thoresen, G. Hege & Aas, Vigdis
(2010).
Chronic hyperglycaemia impairs metabolic switching of human myotubes.
-
Aas, Vigdis; Hessvik, Nina; Thoresen, Hege & Rustan, Arild Chr.
(2010).
Chronic hyperglycaemia impairs mitochondrial function in human myotubes.
-
Bakke, Siril Skaret; Hessvik, Nina Pettersen; Fjørkenstad, Anne; Koster, Gerbrand; Rustan, Arild & Thoresen, G. Hege
(2009).
Eicosapentaenoic acid improves metabolic switching of human myotubes.
Vis sammendrag
In skeletal muscle, glucose oxidation dominates in the fed state, while fat oxidation increases both during fasting and during sustained exercise. Metabolic flexibility is the ability to switch from predominantly lipid oxidation during fasting conditions to suppression of lipid oxidation and increased glucose oxidation during feeding conditions. Loss of metabolic flexibillity is related to insulin resistance in skeletal muscle. Skeletal muscle (myotubes) store fat in lipid droplets and is the major tissue for lipid and glucose oxidation in the body.
We have tested whether treatment with different fatty acids including eicosapentaenoic acid (EPA), linoleic acid (LA), palmitic acid (PA) and oleic acid (OA), as well as activation of the nuclear receptor liver X receptor, could modify metabolic switching of myotubes and whether these changes is correlated to changes in mitochondria or lipid droplets in the cells. Methods used are radiolabeled substrate oxidation assays and live imaging of lipid droplets and mitochondria.
Myotubes were stained with Hoescht, Bodipy 493/503 (lipid droplets) and Mitotracker®Red FM and live imaging was performed using the Scan^R high throughput microscope (Olympus) at the Department of Molecular Biosciences, UiO, NorMIC imaging node. Number, size and size distribution of lipid droplets and mitochondrial content in myotubes dependent on pretreatment was quantified.
Results showed that EPA pretreatment of myotubes increased metabolic switching. Furthermore, preatreatment with EPA, as well as with OA and LA and activation of the nuclear receptor liver X receptor increased the number of lipid droplets per nucleus. Lipid droplet size, size distribution and mitochondrial content were independent of pretreatment conditions. This study suggests a possible favorable effect of EPA on skeletal muscle metabolic switching and glucose utilization.
-
Aas, Vigdis; Wettergreen, Marianne; Hessvik, Nina P.; Thoresen, G. Hege & Rustan, Arild Chr.
(2009).
Chronic hyperglycemia reduces myotube mitochondrial function without changing mitochondrial gene expression or mitochondrial content.
-
Corpeleijn, E; Hessvik, Nina Pettersen; Blaak, EE; Thoresen, G. Hege; Gaster, M & Rustan, Arild
(2008).
Utilization of intramyocellular lipids for oxidation in human skeletal muscle cells from lean and type 2 diabetic subjects.
Diabetologia.
ISSN 0012-186X.
51,
s. S303–S303.
-
Rustan, Arild
(2007).
Legemidler ved behandling av fedme.
-
Aas, Vigdis; Wensaas, Andreas J.; Thoresen, G. Hege; Hallèn, Stefan & Rustan, Arild Chr.
(2007).
Chronic hyperglycemia impairs flexibility related to fatty acid metabolism in human myotubes.
-
Rustan, Arild
(2006).
Insulinresistens i humane skje-lettmuskelceller i kultur: Gunstige metabolske effekter av omega-3 fettsyrer.
Toksikologen.
ISSN 1504-5773.
2.
-
Rustan, Arild
(2006).
FATTY ACID-MEDIATED ACCUMULATION OF TRIACYLGLYCEROL IN MYOTUBES FROM TYPE 2 DIABETICS IS REDUCED BY A PAN-PPAR AGONIST TETRADECYL-THIOACETIC ACID (TTA).
-
Rustan, Arild
(2006).
CELL BASED MULTI-WELL ASSAYS FOR DETECTION OF SUBSTRATE ACCUMULATION AND OXIDATION.
-
Rustan, Arild
(2006).
Metabolism and biological effects of n-3 fatty acids.
-
Aas, Vigdis; Wensaas, Andreas J.; Thoresen, G. Hege & Rustan, Arild Chr.
(2006).
Chronic hyperglycaemia impairs flexibility related to fatty acid metabolism in human myotubes.
-
Florholmen, Geir; Thoresen, G. Hege; Rustan, Arild Chr.; Jensen, Jørgen; Christensen, Geir & Aas, Vigdis
(2006).
Leukaemia Inhibitory Factor Stimulates Glucose Transport in Isolated Cardiomyocytes and Induces Insulin Resistance after Chronic Exposure.
-
-
Florholmen, Geir; Thoresen, G. Hege; Rustan, Arild; Jensen, Jørgen; Christensen, Geir Arve & Aas, Vigdis
(2006).
Leukaemia inhibitory factor stimulates glucose transport in isolated cardiomyocytes and induces insulin resistance after chronic exposure.
-
Iversen, PO; Sorensen, DR; Berge, Rolf Kristian; Rustan, AC & Drevon, CA
(2005).
A sulfur-substituted fatty acid analog improves survival and impairs metastasis in rat models of acute leukemia.
Experimental Hematology.
ISSN 0301-472X.
33.
-
Rustan, Arild & Drevon, Christian A
(2005).
Fatty acids: structures and properties.
Encyclopedia of Life Sciences.
ISSN 1476-9506.
Vis sammendrag
Fatty acids, both free and as part of complex lipids, play a
number of key roles in metabolism – as a major metabolic
fuel (storage and transport of energy), as essential
components of all membranes and as gene regulators. In addition, dietary lipids provide polyunsaturated
fatty acids (PUFAs) that are precursors of powerful
locally acting metabolites, i.e. the eicosanoids. As part of
complex lipids, fatty acids are also important for thermal
and electrical insulation, and for mechanical protection.
Moreover, free fatty acids and their salts may function as
detergents and soaps owing to their amphiphatic properties
and formation of micelles.
-
Rustan, Arild
(2005).
A role for LXR in lipid and glucose metabolism in human skeletal muscle.
-
Rustan, Arild
(2005).
A role for LXR in lipid and glucose metabolism in human skeletal muscle.
Vis sammendrag
Liver X receptors (LXRs) are well known as important actors in cholesterol and lipid metabolism, and have also recently been connected to glucose metabolism. The functional role of LXRs in human skeletal muscle is at present mostly unknown. We have studied the effect of chronic ligand activation by a synthetic LXR agonist (T0901317) on lipid and glucose metabolism in human myotubes. Our results demonstrate that activation of LXRs increased uptake, distribution into complex cellular lipids and oxidation of palmitate, and uptake and oxidation of glucose in myotubes. Consistently, activation of LXRs induced the expression of relevant genes; fatty acid translocase (CD36/FAT), glucose transporters (GLUT1/GLUT4), sterol regulatory element-binding protein-1c (SREBP-1c), peroxisome proliferator-activated receptor (PPARgamma), carnitine palmitoyltransferase-1 (CPT-1) and uncoupling proteins (UCP2/UCP3). Interestingly, in response to activation of LXRs, myotubes from type 2 diabetic subjects showed an elevated uptake and incorporation of palmitate into complex lipids, but absence in palmitate oxidation to CO2. Moreover, results also showed that 22-hydroxycholesterols (22-R-HC and 22-S-HC) had effects on important LXR target genes both for glucose and lipid metabolism. 22-R-HC, which could be an endogenous LXR ligand in human muscle, also increased the mRNA expression of some LXR target genes, but regulated lipid and glucose metabolism differently than T0901317 with less formation of lipids (similar to untreated cells). 22-S-HC was not an inactive ligand in human myotubes, but repressed certain genes involved in lipogenesis and lipid handling, reduced accumulation of complex lipids and increased basal glucose uptake. Taken together, these results provide evidence for a functional role of LXRs in lipid and glucose metabolism and energy uncoupling in human myotubes. Furthermore, these data suggest that increased intramyocellular lipid content in type 2 diabetic subjects may involve an altered response to activation of components in the LXR pathway.
Reference: Kase ET, Wensaas AJ, Aas V, Højlund K, Levin K, Thoresen GH, Beck-Nielsen H, Rustan AC, Gaster M. Diabetes, 2005, 54:1108-1115
-
Florholmen, Geir; Aas, Vigdis; Rustan, Arild; Lunde, Per Kristian; Straumann, Nadine & Eid, Hilde
[Vis alle 10 forfattere av denne artikkelen]
(2005).
Leukemia inhibitory factor reduces contractile function and induces alterations in energy metabolism in isolated cardiomyoctyes.
-
Florholmen, Geir; Thoresen, G. Hege; Rustan, Arild Chr.; Jensen, Jørgen; Christensen, Geir & Aas, Vigdis
(2005).
Leukaemia inhibitory factor stimulates glucose transport in isolated cardiomyocytes and induces insulin resistance after chronic exposure.
-
-
Rustan, Arild
(2004).
Increased fatty acid and glucose metabolism in cultured human myotubes after treatment with the Liver X Receptor (LXR) agonist T0901317.
-
Rudberg, Ida; Florholmen, Geir; Jensen, Jørgen; Rustan, Arild Chr. & Aas, Vigdis
(2004).
Electrical stimulation of human skeletal muscle cells as a model of exercise; effects on insulin signalling and glucose metabolism.
-
Aas, Vigdis; Kase, Eili Tranheim; Wensaas, Andreas J.; Gaster, Michael & Rustan, Arild Chr.
(2004).
Lipid metabolism in human skeletal muscle cells.
-
Aas, Vigdis; Kase, Eili Tranheim; Wensaas, Andreas J.; Thoresen, G. Hege & Rustan, Arild Chr.
(2004).
Lipid metabolism in human skeletal muscle cells.
-
Wensaas, Andreas & Rustan, Arild
(2003).
Tetradecylthioacetic acid (TTA) increases fatty acid oxidation without impairment of glucose utilization in cultured human myotubes.
Vis sammendrag
The hypolipidemic action of the sulfur substituted fatty acid analogue tetradecylthioacetic acid (TTA) is well documented. TTA also decreases hyperglycemia and markedly improves insulin action in animal models of insulin resistance. Moreover, TTA treatment of rats increases insulin-stimulated glucose uptake in skeletal muscle, suggesting that it also influences glucose homeostasis in a favourable way. Based on these observations we studied the effect of TTA on lipid and glucose metabolism in cultured human skeletal muscle cells from healthy young as well as from obese type 2 diabetic subjects (T2D).
Satelitte cells (myoblasts) were isolated from the M. vastus lateralis, and fused to differentiated multinucleated myotubes for 6 days. Fatty acid metabolism was studied using 14C-palmitic acid (PA), glucose transport determined using 3H-2-deoxyglucose and glucose oxidation with 1-14C-glucose.
Preincubation of control and T2D myotubes with TTA (50�100 µM) for 4 days during differentiation resulted in a 20-30 % increase in fatty acid beta-oxidation both under basal conditions and with acute insulin (100 nM) stimulation. At the same time PA esterification into triacylglycerol (TAG) was reduced by approximately 30 %. The effect of TTA on PA oxidation and TAG formation completely disappeared by addition of etomoxir (4 µM) which is an inhibitor of mitochondrial fatty acid oxidation. On the other hand, basal as well as insulin-stimulated glucose uptake was 1.4-fold increased after pretreatment with TTA both in control and T2D myotubes. Moreover, oxidation of glucose to carbondioxide was also slightly increased after exposure to TTA.
Taken together our data suggest that TTA have distinct effects on skeletal muscle causing increased total oxidative capacity in control as well as T2D myotubes. At the same time, TTA prevents TAG accumulation in the cells and increases glucose uptake. These effects may be important for the lipid-lowering and antidiabetic action of TTA.
-
Florholmen, G.; Aas, Vigdis; Rustan, Arild; Ødegaard, Annlaug; Andersson, Kristin Brevik & Christensen, Geir Arve
(2003).
The cytokine leukemia inhibitory factor is an inducer of contractile dysfunction.
-
Rustan, Arild & Aas, Vigdis
(2003).
Redistribution of lipids in cultured myotubes established from T2D subjects - evidence for genetic defects in lipid oxidation in skeletal muscles.
Vis sammendrag
Insulin resistance in skeletal muscle in vivo is associated with impaired glucose transport and glycogen synthesis, which may be linked to lipid accumulation and reduced lipid oxidation. However, it is still uncertain whether observed changes in lipid metabolism represent an adaptive compensation at the cellular level or a direct expression of a primary i.e. genetic trait. Studies in cultured human myotubes may solve this problem since genetic defects will be preserved and expressed also during culture in vitro. In the present study we measured palmitate (PA, 0.6 mM) uptake, PA oxidation and the incorporation of PA into complex cellular lipids in myotubes established from 10 type 2 diabetic (T2D) subjects and 10 matched controls at basal physiological conditions (5.0 mM glucose, 25 pM insulin) and after an acute insulin stimulation (1 µM) to clarify wheather lipid metabolism express defects of genetic origin. Results: Total lipid uptake was similar in myotubes established from the two groups at basal conditions (117.7±16.3 vs 153.6±8.9 nmol/mg cell protein/4h, control vs T2D, p=0.08). However, complete palmitate oxidation was lower in myotubes established from diabetic subjects (5.9±0.6 vs 4.3±0.5 nmol/mg cell protein/4h, p<0.03). Furthermore, the palmitate incorporation into phospholipids was increased in myotubes established from type 2 diabetic subjects (50.0±5.6 vs 68.0±6.6 nmol/mg cell protein/4h, p=0.03). On the other hand, the incorporation of palmiate into diacylglycerol, triacylglyceroland sum of cellular lipid was significantly stimulated by insulin in both study groups (p<0.01), but there was no difference between groups (p>0.05). These findings are consistent with a primary determined redistibution of palmitate from oxidation to accumulation in myotubes established from type 2 diabetic subjects. Thus, our data may explain the reduced lipid oxidation and increased lipid content seen in vivo in skeletal muscles of type 2 diabetic subjects, which may be of genetic origin.
-
Rustan, Arild; Solberg, Roger; Reseland, Janne Elin; Andersen, Merethe H; Drevon, Christian A & Aas, Vigdis
(2002).
Fatty Acids Modulate Leptin And Leptin Receptor (OB-Rb) Gene Expression And Leptin Secretion In Cultured Human Skeletal Muscle Cells.
Vis sammendrag
Background and Aims: Leptin is a hormone primarily secreted by
adipocytes that plays a pivotal role in regulating food intake, energy
expenditure and neuroendocrine function. Leptin stimulates oxidation of
fatty acids and uptake of glucose, and prevents accumulation of lipids
in nonadipose tissues. Inducible leptin expression in skeletal muscle
cells (L6 rat cells) in response to insulin and glucosamine has been
reported (Wang et al., Nature 1998, 393: 684-8). Based on this
observation, we examined if leptin is present in skeletal muscle cells
from human biopsies, and also if leptin and its receptor (OB-Rb) could
be modulated by hormones, fatty acids and other energy substrates.
Materials and Methods: Myoblasts were isolated from the vastus
lateralis of young healthy volunteers and fused to differentiated
multinucleated myotubes. MessengerRNA (mRNA) was isolated by magnetic
beads (Dynal), and quantitative RT-PCR was performed using GeneAmp EZ
rTth RNA PCR kit (Perkin Elmer) with 32P-dCTP. Relative abundance of
phenotype marker mRNAs was calculated as a-tubulin cDNA ratio.
Concentration of leptin in cell culture media was measured by a
competitive radioimmunoassay (Linco Research). Glucose transport was
measured after preincubation with fatty acids using 3H-2-deoxyglucose ±
insulin (100 nM) and cytochalasin B. Results: Leptin was expressed in
differentiated myotubes, and both expression (mRNA) and secretion were
changed after incubation with 0.1-0.6 mM of fatty acids for 24 and 48
h. Oleic acid (OA) and eicosapentaenoic acid (EPA 20:5 n-3) increased
leptin secretion to the culture medium, with the strongest effect of OA
after 48 h incubation. We also observed that incubation with palmitic
acid (PA), OA and EPA for 24 and 48 h increased leptin mRNA expression,
whereas the leptin receptor (OB-Rb) mRNA expression was reduced 40-50 %
by EPA. Moreover, the effect of these fatty acids on basal and
insulin-stimulated glucose metabolism was also examined. Preincubation
with PA and OA (0.6 mM for 24 h) induced insulin resistance assessed by
decreased insulin-stimulated 2-deoxyglucose transport, when compared to
fatty acid-free controls. EPA did not reduce insulin-stimulated glucose
transport, and caused a 2-fold increase in basal as well as
insulin-stimulated glucose transport. Conclusion: We have for the first
time demonstrated leptin expression in human skeletal muscle cells.
Furthermore, this is the first documentation of regulation of OB-Rb in
any tissue examined. The physiological effect of fatty acids on the
leptin axis in muscle cells needs further studies. We focus on how
fatty acids affect leptin, OB-Rb and their signalling pathways in
glucose and lipid metabolism.
-
Rustan, Arild; Solberg, Rigmor; Reseland, Janne Elin; Andersen, Merethe H; Drevon, Christian A & Aas, Vigdis
(2002).
FATTY ACIDS MODULATE LEPTIN AND LEPTIN RECEPTOR (OB-RB) GENE EXPRESSION AND LEPTIN SECRETION IN CULTURED HUMAN SKELETAL MUSCLE CELLS.
Vis sammendrag
Leptin is a hormone primarily secreted by adipocytes that plays a pivotal role in regulating food intake, energy expenditure and neuroendocrine function. Leptin stimulates oxidation of fatty acids and uptake of glucose, and prevents accumulation of lipids in nonadipose tissues. Inducible leptin expression in skeletal muscle cells (L6 rat cells) in response to insulin and glucosamine has been reported (Wang et al., Nature 1998, 393: 684-8). Based on this observation, we examined if leptin is present in skeletal muscle cells from human biopsies, and also if leptin and its receptor (OB-RB) could be modulated by hormones, fatty acids and other energy substrates.
Leptin was expressed in differentiated myotubes, and both expression (mRNA) and secretion were changed after incubation with 0.1-0.6 mM of fatty acids for 24 and 48 h. Oleate (OA) and eicosapentaenoic acid (EPA 20:5 n-3) increased leptin secretion to the culture medium, with the strongest effect of OA after 48 h incubation. We also observed that incubation with palmitate (PA), OA and EPA for 24 and 48 h increased leptin mRNA expression, whereas the leptin receptor (OB-RB) mRNA expression was reduced 40-50 % by EPA. Moreover, the effect of these fatty acids on basal and insulin-stimulated glucose metabolism was also examined. Preincubation with PA and OA (0.6 mM for 24 h) induced insulin resistance assessed by decreased insulin-stimulated 2-deoxy-glucose transport, when compared to fatty acid-free controls. EPA on the other hand, did not reduce insulin-stimulated glucose transport, and caused a 2-fold increase in basal as well as insulin-stimulated glucose transport.
We have for the first time demonstrated leptin expression in human skeletal muscle cells. Furthermore, this is the first documentation of regulation of OB-RB in any tissue examined. The physiological effect of fatty acids on the leptin axis in muscle cells needs further studies. We focus on how fatty acids affect leptin, OB-RB and their signalling pathways in glucose and lipid metabolism.
-
Howe, P.; Hammervold, T.; Meyer, B.; Rustan, Arild & Calvert, D.
(2002).
Omega-3 supplementation improves drug-treatment of hyperlipidaemia.
Vis sammendrag
Preliminary data indicated that combining fish oil supplementation with statin therapy may enhance the cholesterol-lowering effect of the drug as well as improving plasma triglycerides (Howe et al, Australian Atherosclerosis Society, 1998). We sought to confirm this effect in 45 statin-treated patients with persistent mild hypertriglyceridaemia (avg. 2.2 mmol/L) who were randomised to take 4 g/day or 8 g/day of either tuna oil (HiDHA, Clover Corporation) or olive oil (placebo) for 6 months. Plasma lipids were assessed initially and after 3 and 6 months in 40 subjects who completed the trial.
Plasma triglycerides were reduced 13% by 4g and 27% by 8g of fish oil. Moreover, there was a marginally significant 8% decrease in plasma total cholesterol (TC) with 8g of fish oil, even though TC was already well controlled by the statin therapy (avg 4.5 mmol/L). There was no change in TC with the 4g dose. The extent of reduction correlated strongly (r = -0.84) with initial TC levels; the reduction was 13% (p = 0.02) in those subjects (10 per treatment group) with initial TC > 3.8 mmol/L. In this subset, plasma VLDL, IDL and LDL were isolated and assayed for cholesterol and apolipoprotein B. Fish oil tended to lower cholesterol and apoB in VLDL and raise both in LDL. There were no significant changes in IDL-cholesterol, IDL-apoB and HDL-cholesterol. In conclusion, a high intake of DHA-rich fish oil can further improve plasma lipids in patients taking statins and may be preferable to drug combinations for treatment of dyslipidaemia.
-
Madsen, Lise; Berge, Rolf Kristian; Guerre-Millo, Michele; Berge, Kjetil; Bergene, Elin & Flindt, Esben N.
[Vis alle 13 forfattere av denne artikkelen]
(2001).
Expression of PPARa target genes improve insulin action and reduce adiposity.
-
Rustan, Arild & Storlien, Len H.
(2001).
Membrane lipids, storage lipids and insulin action.
Vis sammendrag
Skeletal muscle is the most important tissue for insulin-stimulated glucose metabolism and plays a major role, as well, in lipid metabolism. The liver is the primary organ of endogenous glucose production. Between them, these organs are predominant players in whole-body insulin action. While considerable advances have been made in eludicating the insulin-signalling cascade, the metabolic basis of insulin resistance is still incompletely understood. Two lipid-related variables, the fatty acid composition of phospholipid, the major membrane structural lipid, and the amount and location of accumulated storage lipid have both been closely linked to insulin action in both skeletal muscle and liver, and in both experimental animal and human studies. The general observation of impaired insulin action with increased saturation of membrane lipid has now been made under numerous conditions. Mechanisms are still not entirely clear, but may include both direct ones, eg, the protein kinase B (PKB) and/or protein kinase C (PKC) signalling systems, or indirect ones via changes in the physiochemical properties of membranes and hence either changes in membrane protein intrinsic activity or passive ion leakiness and thus cellular energy requirements. Similarly, the linkage of increased storage lipid with insulin resistance has been confirmed and shown, by both non-invasive imaging and direct measurement, to result from triacylglycerol actually within muscle myocytes in the case of skeletal muscle. Factors which control intramyocyte lipolysis and production, for example, of long-chain acyl CoA (LCACoA) and diacylglycerol (DAG) are likely to prove critical to modulation of insulin action. In summary, lipids play multiple roles in insulin action and the complete understanding of these processes will teach us much about how to ameliorate insulin resistance.
-
Howe, P.R.C.; Hammervold, T.; Meyer, B.; Rustan, Arild & Calvert, G.D.
(2001).
EFFECTS OF FISH OIL SUPPLEMENTATION IN STATIN-TREATED SUBJECTS WITH PERSISTENT HYPERTRIGLYCERIDAEMIA.
Vis sammendrag
Preliminary data indicated that combining fish oil supplementation with statin therapy may enhance the cholesterol-lowering effect of the drug as well as improving plasma triglycerides (Howe et al, Australian Atherosclerosis Society, 1998). We sought to confirm this effect in 45 statin-treated patients with persistent mild hypertriglyceridaemia (avg. 2.2mmol/L) who were randomised to take 4 g/day or 8 g/day of either tuna oil (HiDHA, Clover Corporation) or olive oil (placebo) for 6 months. Plasma lipids were assessed initially and after 3 and 6 months in 40 subjects who completed the trial.
As shown in the figure, daily supplementation with 8g of fish oil caused a 27% reduction of plasma triglycerides. Moreover, there was a marginally significant 8% decrease in plasma total cholesterol (TC) with 8g of fish oil, even though TC was already well controlled by the statin therapy (avg 4.5mmol/L). There was no change in TC with the 4g dose. The extent of reduction correlated strongly (r = -0.84) with initial TC levels; the reduction was 13% (p = 0.02) in those subjects (10 per treatment group) with initial TC > 3.8 mmol/L. In this subset, plasma VLDL, IDL and LDL were isolated and assayed for cholesterol and apolipoprotein B. Although not significant, fish oil tended to lower cholesterol and apoB in VLDL and raise both in LDL. There were no significant changes in IDL-cholesterol, IDL-apoB and HDL-cholesterol. In conclusion, a high intake of DHA-rich fish oil can further improve plasma lipids in patients taking statins and may be preferable to drug combinations for treatment of dyslipidaemia.
-
Howe, P.R.C.; Hammervold, T.; Meyer, B.; Rustan, Arild & Calvert, G.D.
(2001).
Omega-3 supplementation improves drug-treatment of hyperlipidaemia.
Vis sammendrag
Preliminary data indicated that adding fish oil to statin therapy may enhance the cholesterol-lowering effect of the drug as well as improving plasma triglycerides (Howe et al, Australian Atherosclerosis Society, 1998). We sought to confirm this effect in 45 statin-treated patients with persistent mild hypertriglyceridaemia (avg. 2.2mM) who were randomised to take a daily dose of 4g or 8g of either DHA-rich tuna oil or placebo (olive oil) for 6 months. Forty subjects completed the trial. Plasma lipids, blood pressure and arterial compliance were assessed initially and after 3 and 6 months. In subjects with initial plasma total cholesterol (TC) >3.8mmol/L, VLDL, IDL, LDL were isolated and assayed for cholesterol and apolipoprotein B. The results showed a significant reduction in plasma triglycerides of 13% by 4g and 27% by 8g fish oil. Even though plasma total cholesterol (TC) was already well controlled by statins (avg 4.5mM), there was a further marginally significant (p = 0.05 compared with placebo) reduction (averaging 8% at 3 and 6 months) with 8g of fish oil. No changes in TC were seen with the 4g dose. As the extent of reduction correlated strongly (r = -0.84) with initial levels, the reduction was 13% (p = 0.02) in those subjects with initial TC>3.8mM. Although not significant, fish oil tended to lower VLDL-cholesterol and VLDL-apoB and raise both in LDL. There were no significant changes in IDL-cholesterol, IDL-apoB and HDL-cholesterol. Thus, fish oil supplementation has the potential to further improve lipids and possibly reduce drug requirements in statin-treated hypercholesterolaemia.
-
Rasch-Halvorsen, Mathias; McLennan, Peter & Rustan, Arild
(2001).
EFFECT OF INDIVIDUAL FATTY ACIDS ON 2-DEOXY-D-GLUCOSE UPTAKE IN CULTURED HUMAN SKELETAL MUSCLE CELLS.
-
Aas, Vigdis; Torblå, Siri; Andersen, Merethe H; Jensen, Jørgen & Rustan, Arild
(2001).
Electrical Stimulation Improves Insulin Responses in a Human Skeletal Muscle Cell Model of Hyperglycemia.
Vis sammendrag
Abstract
In order to examine mechanisms involved in insulin resistance, we have established an in vitro model. Myoblasts from human skeletal muscle were isolated from needle biopsy samples of the vastus lateralis of young and healthy volunteers. Contaminating fibroblasts were removed, and myoblasts were fused to differentiated multinucleated myotubes. These myotubes manifested both basal and insulin-stimulated (1-100 nM) glucose transport as well as intracellular glucose metabolism. Insulin increased 2-deoxyglucose uptake 1.4-fold and glycogen synthesis 2.1-fold. Acute electrical stimulation of the myotubes increased 2-deoxyglucoseuptake by about 30 %. Measurements of impedance of cell-covered gold electrodes (ECIS system) showed increased micromotion of caffeine stimulated cells, implying an ability to contract. Treatment with high glucose concentrations for 2-8 days reduced both basal and insulin-stimulated glucose uptake. Maximal effect was seen already after 2 days treatment with 20 mM glucose. Then baseline glucose uptake and glycogen synthesis was reduced by 35 %, insulin stimulated glucose uptake by 25 % and glycogen synthesis by 39 %, respectively. Total cell content of glycogen was not changed by hyperglycemia. The insulin-stimulated glucose uptake in hyperglycemia treated cells was improved by electrical stimulation of the cells. In conclusion, a model of hyperglycemia has been established, and electrical stimulation improved insulin responses.
-
Rustan, Arild; Torblå, Siri; Andersen, Merethe H; Jensen, Jørgen; Storlien, Len H. & Aas, Vigdis
(2001).
HUMAN SKELETAL MUSCLE CELL CULTURES AS A MODEL OF INSULIN RESISTANCE.
Vis sammendrag
Defects in insulin action (insulin resistance) and resultant hyperinsulinemia are strongly linked to the development of type II diabetes (NIDDM) and dyslipidemias. A number of defects in insulin signaling components have been described in insulin resistance. However, it is not clear how these defects appear and how they affect glucose metabolism.
Skeletal muscle is the major site of insulin-stimulated glucose metabolism. In order to examine mechanisms involved in insulin resistance, we have established an in vitro cell culture model. Myoblasts were isolated from the vastus lateralis of young healthy volunteers and fused to differentiated multinucleated myotubes. Insulin (0.1-100 nM) increased glucose uptake, glucose oxidation and glycogen synthesis up to 2-fold in these cells. Electrical stimulation of the myotubes increased glucose uptake by about 40%. Measurements of impedance of cell-covered gold electrodes (ECIS system) showed increased micromotion of caffeine stimulated cells, implying an ability to contract. The cells also responded well to insulin at the level of insulin receptor substrate-1 (IRS-1) phosphorylation, activation of phosphoinositide 3-kinase (PI3-K) and protein kinase B (PKB). Preincubation of myotubes with fatty acids (0.6-2 mM oleic and palmitic acid) or high glucose concentration (10-20 mM) induced insulin resistance assessed by decreased glucose uptake, glycogen synthesis and glucose oxidation.
-
Rustan, Arild; Andersen, Merethe H; Storlien, Len H.; Berge, Rolf Kristian; Schmitz-Peiffer, Carsten & Aas, Vigdis
(2001).
FATTY ACID-INDUCED INSULIN RESISTANCE IN HUMAN SKELETAL MUSCLE CELLS.
Vis sammendrag
Skeletal muscle is the major site of insulin-stimulated glucose disposal, and free fatty acids (FFAs) are thought to have diversified effects on muscle insulin action by mechanisms linked to membrane incorporation, increased muscle triacylglycerol storage and increased lipid oxidation. It has also been suggested inhibition of insulin signalling and glucose uptake as well as glycogen synthesis following treatment with fatty acids. Both acute treatment (<4 h) and preincubation (24 h) of myotubes with saturated (palmitate) and monounsaturated (oleate) fatty acids (0.6-2 mM) induced insulin resistance assessed by decreased insulin-stimulated glucose uptake (by 40-60 %), glycogen synthesis (by 20-60 %) and glucose oxidation (by 50%). The mechanism for the acute reduction of glucose utilization by fatty acids was further examined. Tetradecylthioacetic acid (TTA) (a non-b-oxidizable hypolipidemic fatty acid analogue) also decreased glucose oxidation, and etomoxir (a fatty acid oxidation inhibitor) did not prevent the inhibitory effect of fatty acids on glucose oxidation, suggesting no direct substrate competition. Moreover, the fatty acid oleate and TTA did not affect insulin signalling at the level of IRS-1, PI3-K and PKB. At present, we are focusing on how fatty acids affect enzymes and other signalling components involved in glucose and lipid metabolism
-
Torblå, Siri; Andersen, Merethe H; Jensen, Jørgen; Rustan, Arild & Aas, Vigdis
(2001).
HUMAN SKELETAL MUSCLE CELL CULTURES AS A MODEL OF INSULIN RESISTANCE.
Vis sammendrag
Skeletal muscle is the major site of insulin-stimulated glucose metabolism. Defects in insulin action (¿insulin resistance¿) and resultant hyperinsulinemia are strongly linked to the development of a cluster of prevalent diseases, including type II diabetes (NIDDM), obesity, dyslipidemias, hypertension and heart disease. In recent years, a number of defects in insulin signaling components have been described in insulin resistance. However, it is not clear how these defects appear, which are critical and how they affect glucose metabolism.
In order to examine mechanisms involved in insulin resistance, we have established an in vitro model. Myoblasts from human skeletal muscle were isolated from needle biopsy samples of the vastus lateralis of young and healthy volunteers. Contaminating fibroblasts were removed, and myoblasts were fused to differentiated multinucleated myotubes. These myotubes manifest both basal and insulin-stimulated (1-1000 nM) glucose transport as well as intracellular glucose metabolism that resemble the in vivo situation. Insulin increased 2-deoxyglucose uptake, glucose oxidation and glycogen synthesis 1.2-2-fold. Acute electrical stimulation of the myotubes increased 2-deoxyglucose-uptake by about 40 %. It was impossible to visually detect contractile activity, but measurements of impedance of cell-covered gold electrodes (ECIS system), showed increased micromotion of caffeine stimulated cells, implying an ability to contract. Contractile activity was confirmed by an increase in glucose oxidation upon electrical stimulation. The cells also responded well to insulin at the level of insulin receptor substrate-1 (IRS-1) phosphorylation, activation of phosphoinositide 3-kinase (PI3-K) and protein kinase B (PKB). Preincubation of myotubes with free fatty acids (0.6-2 mM oleic acid and palmitic acid) or high glucose concentration (10-20 mM) induced ¿insulin resistance¿ assessed by decreased glucose uptake and oxidation.
So far the cell system is well characterized and found convenient for investigations on mechanisms involved in different models of insulin resistance. The effect of free fatty acids and high glucose concentration on insulin signaling components will be further studied. In addition, we want to examine if contractile activity can improve insulin sensitivity in this system.
-
Andersen, Merethe H; Storlien, Len H.; Aas, Vigdis; Berge, Rolf Kristian; Schmitz-Peiffer, Carsten & Rustan, Arild
(2001).
Fatty acid-induced insulin resistance in human skeletal muscle cells.
Vis sammendrag
Skeletal muscle is the major site of insulin-stimulated glucose disposal, and free fatty acids (FFAs) are thought to have diversified effects on muscle insulin action by mechanisms linked to membrane incorporation, increased muscle triacylglycerol storage and increased lipid oxidation. It has also been suggested inhibition of insulin signalling and glucose uptake as well as glycogen synthesis following treatment with fatty acids. Both acute treatment (<4 h) and preincubation (24 h) of myotubes with saturated (palmitate) and monounsaturated (oleate) fatty acids (0.6-2 mM) induced insulin resistance assessed by decreased insulin-stimulated glucose uptake (by 40-60 %), glycogen synthesis (by 20-60 %) and glucose oxidation (by 50%). The mechanism for the acute reduction of glucose utilization by fatty acids was further examined. Tetradecylthioacetic acid (a non-b-oxidizable fatty acid analogue) also decreased glucose oxidation, and etomoxir (a fatty acid oxidation inhibitor) did not prevent the inhibitory effect of fatty acids on glucose oxidation, suggesting no direct substrate competition. Moreover, the fatty acid oleate did not affect insulin signalling at the level of IRS-1, PI3-K and PKB. At present, we are focusing on how fatty acids affect enzymes and other signalling components involved in glucose metabolism.
-
Rustan, Arild; Torblå, Siri; Andersen, Merethe H; Jensen, Jørgen; Storlien, Len H. & Aas, Vigdis
(2001).
Human skeletal muscle cell cultures as a model of insulin resistance.
Vis sammendrag
Defects in insulin action (insulin resistance) and resultant hyperinsulinemia are strongly linked to the development of type II diabetes (NIDDM) and dyslipidemias. A number of defects in insulin signaling components have been described in insulin resistance. However, it is not clear how these defects appear and how they affect glucose metabolism.
Skeletal muscle is the major site of insulin-stimulated glucose metabolism. In order to examine mechanisms involved in insulin resistance, we have established an in vitro cell culture model. Myoblasts were isolated from the vastus lateralis of young healthy volunteers and fused to differentiated multinucleated myotubes. Insulin (1-1000 nM) increased glucose uptake, glucose oxidation and glycogen synthesis up to 2-fold in these cells. Electrical stimulation of the myotubes increased glucose uptake by about 40%. Measurements of impedance of cell-covered gold electrodes (ECIS system) showed increased micromotion of caffeine stimulated cells, implying an ability to contract. The cells also responded well to insulin at the level of insulin receptor substrate-1 (IRS-1) phosphorylation, activation of phosphoinositide 3-kinase (PI3-K) and protein kinase B (PKB). Preincubation of myotubes with fatty acids (0.6-2 mM oleic and palmitic acid) or high glucose concentration (10-20 mM) induced insulin resistance assessed by decreased glucose uptake and metabolism.
-
Rustan, Arild
(2000).
Lipid-induced insulin resistance in human skeletal muscle primary culture.
-
Rustan, Arild
(2000).
Lipid-induced insulin resistance in human skeletal muscle cells.
-
Rustan, Arild
(2000).
Lipid-induced insulin resistance in human skeletal muscle cells.
-
Ukropec, Jozef; Klimes, Ivar; Gasperikova, D.; Reseland, Janne Elin; Drevon, Christian A & Rustan, Arild
[Vis alle 7 forfattere av denne artikkelen]
(2000).
Decreased leptin expression is associated with hypertriglyceridemic effect of fish oil.
-
Sebokova, Elena; Ucropec, J.; Reseland, Janne Elin; Rustan, Arild; Drevon, Christian A & Klimes, Ivar
(2000).
Hypotriglyceridemic effect of n-3 PUFA is associated with decreased leptin expression.
-
Sebokova, Elena; Ukropec, Jozef; Rustan, Arild; Reseland, Janne Elin; Drevon, Christian A & Klimes, Ivar
(2000).
Correction of diet-induced hyperleptinemia and insulin resistance by n-3 PUFAs is associated with increased fatty acid oxidation.
-
Berge, Rolf Kristian; Madsen, Lars; Guerre-Millo, Michele; Berge, K.; Bergene, Elin & Flint, E. N.
[Vis alle 13 forfattere av denne artikkelen]
(2000).
Expression of PPARalpha target genes improve insulin action and reduce adiposity.
-
Madsen, Lars; Vaagenes, H.; Rustan, Arild & Berge, Rolf Kristian
(2000).
In contrast to docosahexaenoic acid, eicosapentaenoic acid and hypolipidemic derivatives reduce hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation.
-
Cazzolli, R.; Rustan, Arild; Biden, T. J. & Schmitz-Peiffer, Carsten
(2000).
Lipid-induced insulin resistance in human skeletal muscle primary culture.
-
Rustan, Arild
(1999).
Energy transport and fatty acids: with focus on omega-3 fatty acids and the insulin resistance syndrome.
-
Rustan, Arild
(1999).
3-thia fatty acids. Metabolism and metabolic effects.
-
Gedde-Dahl, Ane & Rustan, Arild
(1998).
Tetradecylthioacetic acid (a 3-thia fatty acid) decreases secretion of newly synthesized, but not preformed, triacylglycerol in CaCo-2 cells.
-
Rustan, Arild
(1998).
Omega-3 and Omega-6 fatty acids in the insulin resistance syndrome (IRS).